Scientists have long searched for a prescription to treat addiction. But companies were hesitant to develop one. Charles O’Keeffe is the former president and CEO of Reckitt Benckiser, the company that developed Suboxone. “There’s not much money to be made in it,” says O’Keeffe. “This is not a disease space that a lot of people want to treat.